Fintel reports that on April 28, 2025, Cantor Fitzgerald initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Overweight recommendation. Analyst Price Forecast Suggests 266.21% Upside As ...

This means that our MLB handicappers here at Doc's have a boatload of games in which to offer premium and free MLB picks to our readers. All lines are scrutinized each night so we can bring you ...